At close: December 20 at 4:00:01 PM EST
After hours: December 20 at 5:27:44 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 353,491 | 23 |
| Sales | 354,536 | 16 |
| Net Shares Purchased (Sold) | -1,045 | 39 |
| Total Insider Shares Held | 323.88k | -- |
| % Net Shares Purchased (Sold) | -0.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEE JENNIFER KAYDEN Officer | Sale at price 65.68 - 68.43 per share. | Direct | 4,434,882 | Nov 11, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 65.73 - 67.83 per share. | Direct | 882,341 | Nov 11, 2024 |
| LEE JENNIFER KAYDEN Officer | Conversion of Exercise of derivative security at price 6.80 - 30.66 per share. | Direct | 1,194,709 | Nov 11, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Conversion of Exercise of derivative security at price 6.80 - 21.38 per share. | Direct | 167,760 | Nov 11, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 60.00 - 65.00 per share. | Direct | 585,940 | Nov 7, 2024 |
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 19.02 per share. | Direct | 178,312 | Nov 7, 2024 |
| GOOD JENNIFER L Director | Sale at price 52.40 per share. | Direct | 1,663,803 | Sep 17, 2024 |
| GOOD JENNIFER L Director | Conversion of Exercise of derivative security at price 18.99 - 22.93 per share. | Direct | 684,066 | Sep 17, 2024 |
| TETRAULT LYNN A. Director | Sale at price 49.05 - 50.60 per share. | Direct | 1,028,991 | Sep 10, 2024 |
| TETRAULT LYNN A. Director | Conversion of Exercise of derivative security at price 4.15 - 18.99 per share. | Direct | 244,693 | Sep 10, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 50.03 per share. | Direct | 205,062 | Sep 9, 2024 |
| GOOD JENNIFER L Director | Sale at price 50.45 per share. | Direct | 1,878,700 | Sep 9, 2024 |
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 19.02 per share. | Direct | 77,963 | Sep 9, 2024 |
| GOOD JENNIFER L Director | Conversion of Exercise of derivative security at price 4.15 - 22.93 per share. | Direct | 496,706 | Sep 9, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 50.01 per share. | Direct | 160,018 | Aug 26, 2024 |
| GOOD JENNIFER L Director | Sale at price 50.01 per share. | Direct | 725,526 | Aug 26, 2024 |
| TETRAULT LYNN A. Director | Sale at price 50.01 per share. | Direct | 215,029 | Aug 26, 2024 |
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 19.02 per share. | Direct | 60,864 | Aug 26, 2024 |
| GOOD JENNIFER L Director | Conversion of Exercise of derivative security at price 4.15 - 22.93 per share. | Direct | 270,322 | Aug 26, 2024 |
| TETRAULT LYNN A. Director | Conversion of Exercise of derivative security at price 18.99 per share. | Direct | 81,657 | Aug 26, 2024 |
| TETRAULT LYNN A. Director | Sale at price 44.62 - 45.37 per share. | Direct | 446,462 | Aug 12, 2024 |
| TETRAULT LYNN A. Director | Conversion of Exercise of derivative security at price 4.15 per share. | Direct | 41,500 | Aug 12, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 45.13 - 45.62 per share. | Direct | 2,212,498 | Aug 9, 2024 |
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 19.02 per share. | Direct | 585,264 | Aug 9, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 49.06 per share. | Direct | 68,439 | Jul 29, 2024 |
| CRAMER PAMELA J. Officer | -- | Direct | -- | Jul 26, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 53.00 per share. | Direct | 554,817 | Jul 16, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Conversion of Exercise of derivative security at price 27.35 per share. | Direct | 286,300 | Jul 16, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 50.01 per share. | Direct | 265,725 | Jul 12, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Conversion of Exercise of derivative security at price 21.38 per share. | Direct | 113,592 | Jul 12, 2024 |
| GOOD JENNIFER L Director | -- | Direct | -- | Jun 21, 2024 |
| BEDROSIAN CAMILLE L Director | -- | Direct | -- | Jun 21, 2024 |
| MCGIRR DAVID W J Director | -- | Direct | -- | Jun 21, 2024 |
| MATHERS EDWARD T. Director | -- | Direct | -- | Jun 21, 2024 |
| JEAN CHRISTOPHE R Director | -- | Direct | -- | Jun 21, 2024 |
| ARBUCKLE STUART A Director | -- | Direct | -- | Jun 21, 2024 |
| TETRAULT LYNN A. Director | -- | Direct | -- | Jun 21, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 38.38 - 39.10 per share. | Direct | 153,259 | May 9, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Conversion of Exercise of derivative security at price 6.80 per share. | Direct | 27,091 | May 9, 2024 |
| MAZABRAUD YANN Officer | -- | Direct | -- | Apr 12, 2024 |
| GERMAN CHRISTOPHER PAUL Officer | Sale at price 41.76 per share. | Direct | 15,368 | Apr 2, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 40.34 per share. | Direct | 735,600 | Mar 21, 2024 |
| LEE JENNIFER KAYDEN Officer | Sale at price 38.22 - 39.33 per share. | Direct | 707,005 | Mar 20, 2024 |
| GERMAN CHRISTOPHER PAUL Officer | -- | Direct | -- | Mar 20, 2024 |
| MAZABRAUD YANN Officer | Sale at price 39.22 per share. | Direct | 627,520 | Mar 19, 2024 |
| LEE JENNIFER KAYDEN Officer | Sale at price 39.22 per share. | Direct | 608,498 | Mar 19, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 39.22 per share. | Direct | 608,498 | Mar 19, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 39.22 per share. | Direct | 608,498 | Mar 19, 2024 |
| MEEKER DAVID P Chief Executive Officer | Sale at price 39.22 per share. | Direct | 1,784,275 | Mar 19, 2024 |
| SMITH HUNTER C Chief Financial Officer | Sale at price 39.22 per share. | Direct | 608,498 | Mar 19, 2024 |
Related Tickers
SLNO Soleno Therapeutics, Inc.
45.18
-0.04%
MIRM Mirum Pharmaceuticals, Inc.
41.51
+0.92%
KRYS Krystal Biotech, Inc.
164.83
+2.49%
KYMR Kymera Therapeutics, Inc.
40.66
+3.88%
CYTK Cytokinetics, Incorporated
48.87
+4.56%
PTGX Protagonist Therapeutics, Inc.
41.49
+4.93%
IDYA IDEAYA Biosciences, Inc.
25.61
+3.31%
IONS Ionis Pharmaceuticals, Inc.
35.63
+0.11%
BPMC Blueprint Medicines Corporation
90.14
+1.36%
ASND Ascendis Pharma A/S
136.38
-0.99%